直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
    • AI + Finnegan
    • Appeals, Issues, and Legal Strategy
    • Diligence, Licensing, and Opinions
    • Global IP Enforcement, Litigation, and Trials
    • Patent Office Invalidation Proceedings
    • Prosecution and Portfolio Management
    • Trademark and Brand Management
    • AI, Electronics, and Information Technology
    • Chemicals, Industrials, and Materials
    • Communications
    • Consumer Goods and Services
    • Energy
    • Hospitality, Gaming, and Leisure
    • Life Sciences
    • Transportation and Logistics
  • Experience

Experience

Eli Lilly and Co. v. Apotex Inc.

Eli Lilly and Company

Apotex Inc.

Represented Eli Lilly in multiple ANDA challenges to Orange Book listed patents covering its Prozac® pharmaceutical product.

Eli Lilly and Company v. Apotex Inc., 96-cv-00491, S.D. Ind., Judges Barker, Shields

Related Practices

Global IP Enforcement, Litigation, and Trials

Patent Litigation and Trials

Branded Hatch-Waxman (ANDA) Litigation and Trials

Related Industries

Life Sciences

Pharmaceutical

Related Experiences

Eli Lilly and Company v. Sicor Pharmaceuticals, Inc.

Eli Lilly and Company

Eli Lilly & Co. v. Wockhardt Ltd.

Eli Lilly and Company

Eli Lilly and Company v. Teva Pharmaceuticals USA, Inc.

Eli Lilly and Company

Finnegan represented Eli Lilly on first genetically engineered biologic in the United States

Eli Lilly and Company

Eli Lilly and Company v. Perrigo Co.

Eli Lilly and Company

Sun Pharmaceutical Inds. v. Eli Lilly and Co. 

Eli Lilly and Company

Synthon Pharmaceuticals, Inc. v. Eli Lilly and Co.

Eli Lilly and Co.; ICOS

Eli Lilly and Company v. Genentech, Inc.

Eli Lilly and Company

Eli Lilly and Co. wins challenge to patents covering its osteoporosis drug, Evista®

Eli Lilly and Company

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP